Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy

Nilay Thakkar, Albert Lockhart, Wooin Lee

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The superfamily of organic anion-transporting polypeptides (OATPs, gene symbol SLCO) includes important transporters handling a variety of endogenous and xenobiotic substrates. Currently, 11 human OATPs are known and their substrates include endogenous hormones and their conjugates, anticancer drugs, and imaging agents. The contribution of OATPs to the in vivo disposition of these substrates has been extensively investigated. An accumulating body of evidence also indicates that the expression of some OATPs may be up- or downregulated in several types of cancers, suggesting potential pathogenic roles during the development and progression of cancer. Given that the role of OATPs in handling cancer therapeutics has been already covered by several excellent reviews, this review will focus on the recent progresses on the topic, in particular the role of OATPs in the disposition of anticancer drugs, the impact of OATP genetic variations on the function of OATPs, and the OATPs differentially expressed in cancer and their potential roles in cancer development, progression, and treatment.

Original languageEnglish (US)
Pages (from-to)535-545
Number of pages11
JournalAAPS Journal
Volume17
Issue number3
DOIs
StatePublished - May 1 2015
Externally publishedYes

Fingerprint

Anions
Peptides
Neoplasms
Therapeutics
Xenobiotics
Pharmaceutical Preparations
Down-Regulation
Hormones
Genes

Keywords

  • cancer therapy
  • organic anion-transporting polypeptides
  • transporters

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy. / Thakkar, Nilay; Lockhart, Albert; Lee, Wooin.

In: AAPS Journal, Vol. 17, No. 3, 01.05.2015, p. 535-545.

Research output: Contribution to journalArticle

Thakkar, Nilay ; Lockhart, Albert ; Lee, Wooin. / Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy. In: AAPS Journal. 2015 ; Vol. 17, No. 3. pp. 535-545.
@article{478ed553b8d74ad2b70f9dfc4f94cd94,
title = "Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy",
abstract = "The superfamily of organic anion-transporting polypeptides (OATPs, gene symbol SLCO) includes important transporters handling a variety of endogenous and xenobiotic substrates. Currently, 11 human OATPs are known and their substrates include endogenous hormones and their conjugates, anticancer drugs, and imaging agents. The contribution of OATPs to the in vivo disposition of these substrates has been extensively investigated. An accumulating body of evidence also indicates that the expression of some OATPs may be up- or downregulated in several types of cancers, suggesting potential pathogenic roles during the development and progression of cancer. Given that the role of OATPs in handling cancer therapeutics has been already covered by several excellent reviews, this review will focus on the recent progresses on the topic, in particular the role of OATPs in the disposition of anticancer drugs, the impact of OATP genetic variations on the function of OATPs, and the OATPs differentially expressed in cancer and their potential roles in cancer development, progression, and treatment.",
keywords = "cancer therapy, organic anion-transporting polypeptides, transporters",
author = "Nilay Thakkar and Albert Lockhart and Wooin Lee",
year = "2015",
month = "5",
day = "1",
doi = "10.1208/s12248-015-9740-x",
language = "English (US)",
volume = "17",
pages = "535--545",
journal = "AAPS Journal",
issn = "1522-1059",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy

AU - Thakkar, Nilay

AU - Lockhart, Albert

AU - Lee, Wooin

PY - 2015/5/1

Y1 - 2015/5/1

N2 - The superfamily of organic anion-transporting polypeptides (OATPs, gene symbol SLCO) includes important transporters handling a variety of endogenous and xenobiotic substrates. Currently, 11 human OATPs are known and their substrates include endogenous hormones and their conjugates, anticancer drugs, and imaging agents. The contribution of OATPs to the in vivo disposition of these substrates has been extensively investigated. An accumulating body of evidence also indicates that the expression of some OATPs may be up- or downregulated in several types of cancers, suggesting potential pathogenic roles during the development and progression of cancer. Given that the role of OATPs in handling cancer therapeutics has been already covered by several excellent reviews, this review will focus on the recent progresses on the topic, in particular the role of OATPs in the disposition of anticancer drugs, the impact of OATP genetic variations on the function of OATPs, and the OATPs differentially expressed in cancer and their potential roles in cancer development, progression, and treatment.

AB - The superfamily of organic anion-transporting polypeptides (OATPs, gene symbol SLCO) includes important transporters handling a variety of endogenous and xenobiotic substrates. Currently, 11 human OATPs are known and their substrates include endogenous hormones and their conjugates, anticancer drugs, and imaging agents. The contribution of OATPs to the in vivo disposition of these substrates has been extensively investigated. An accumulating body of evidence also indicates that the expression of some OATPs may be up- or downregulated in several types of cancers, suggesting potential pathogenic roles during the development and progression of cancer. Given that the role of OATPs in handling cancer therapeutics has been already covered by several excellent reviews, this review will focus on the recent progresses on the topic, in particular the role of OATPs in the disposition of anticancer drugs, the impact of OATP genetic variations on the function of OATPs, and the OATPs differentially expressed in cancer and their potential roles in cancer development, progression, and treatment.

KW - cancer therapy

KW - organic anion-transporting polypeptides

KW - transporters

UR - http://www.scopus.com/inward/record.url?scp=84939998522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939998522&partnerID=8YFLogxK

U2 - 10.1208/s12248-015-9740-x

DO - 10.1208/s12248-015-9740-x

M3 - Article

C2 - 25735612

AN - SCOPUS:84939998522

VL - 17

SP - 535

EP - 545

JO - AAPS Journal

JF - AAPS Journal

SN - 1522-1059

IS - 3

ER -